The Public Investment Fund (PIF) has launched Lifera, a commercial-scale CDMO to grow Saudi Arabia’s local biopharmaceutical industry. PIF is the sovereign wealth fund of Saudi Arabia with a goal of making targeted investments and forging partnerships to bolster Saudi Arabia’s supply chain, skills, resource development, pharmaceutical products, job opportunities, and allow for technology transfer from global private sector partners. Financial details of its latest move remain undisclosed, but the organization has launched contract development manufacturing organization (CDMO) Lifera in…

Funded by the Queensland Government, Vaxass has opened a facility in Brisbane, Australia to support the production of its high-density microarray patches. Vaxxas, a clinical-stage biotechnology firm developing vaccine platform technology, has opened a 60,000 square-foot facility in Brisbane, Queensland. The facility includes two GMP aseptic cleanrooms, a device assembly cleanroom, medical device manufacturing space, as well as laboratories and office space. The plant has 130 employees and expects to hire an additional 70 members of staff over the next…